Works matching IS 08991987 AND DT 2019 AND VI 58 AND IP 4

Results: 14

Uridine‐cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 603, doi. 10.1002/mc.22954
By:
- Huang, Shanzhou;
- Li, Jian;
- Tam, Nga Lei;
- Sun, Chengjun;
- Hou, Yuchen;
- Hughes, Bridget;
- Wang, Zekang;
- Zhou, Qi;
- He, Xiaoshun;
- Wu, Linwei
Publication type:
Article
Whole‐exome sequencing reveals novel genetic variants associated with diverse phenotypes of melanoma cells.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 588, doi. 10.1002/mc.22953
By:
- Hartman, Mariusz L.;
- Sztiller‐Sikorska, Malgorzata;
- Czyz, Malgorzata
Publication type:
Article
Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA‐128 and modulating MAPK1.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 577, doi. 10.1002/mc.22952
By:
- Xu, Mei;
- Zhou, Kai;
- Wu, Yuanzhe;
- Wang, Li;
- Lu, Su
Publication type:
Article
Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 565, doi. 10.1002/mc.22951
By:
- Zheng, Hailun;
- Yang, Lehe;
- Kang, Yanting;
- Chen, Min;
- Lin, Shichong;
- Xiang, Youqun;
- Li, Caleb;
- Dai, Xuanxuan;
- Huang, Xiaoying;
- Liang, Guang;
- Zhao, Chengguang
Publication type:
Article
hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR‐7‐5p and activating the MAPK/ERK signaling pathway.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 554, doi. 10.1002/mc.22950
By:
- Gao, Danfeng;
- Qi, Xiaowei;
- Zhang, Xiufen;
- Fang, Kai;
- Guo, Zijian;
- Li, Lihua
Publication type:
Article
Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 544, doi. 10.1002/mc.22949
By:
- Khadirnaikar, Seema;
- Kumar, Pranjal;
- Pandi, Sathiya N.;
- Malik, Rohit;
- Dhanasekaran, Saravana M.;
- Shukla, Sudhanshu Kumar
Publication type:
Article
Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient‐derived esophageal tumor growth.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 533, doi. 10.1002/mc.22948
By:
- Liu, Feifei;
- Zu, Xueyin;
- Xie, Xiaomeng;
- Liu, Kangdong;
- Chen, Hanyong;
- Wang, Ting;
- Liu, Fangfang;
- Bode, Ann M.;
- Zheng, Yan;
- Dong, Zigang;
- Kim, Dong Joon
Publication type:
Article
Butyrate inhibits HBV replication and HBV‐induced hepatoma cell proliferation via modulating SIRT‐1/Ac‐p53 regulatory axis.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 524, doi. 10.1002/mc.22946
By:
- Pant, Kishor;
- Mishra, Amit K.;
- Pradhan, Saman Man;
- Nayak, Baibaswata;
- Das, Prasenjit;
- Shalimar, Dr;
- Saraya, Anoop;
- Venugopal, Senthil K.
Publication type:
Article
Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal‐appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 511, doi. 10.1002/mc.22945
By:
- Kwan, Albert K.;
- Um, Caroline Y.;
- Rutherford, Robin E.;
- Seabrook, March E.;
- Barry, Elizabeth L.;
- Fedirko, Veronika;
- Baron, John A.;
- Bostick, Roberd M.
Publication type:
Article
NRP‐1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 488, doi. 10.1002/mc.22943
By:
- Grun, Daniel;
- Adhikary, Gautam;
- Eckert, Richard L.
Publication type:
Article
TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 474, doi. 10.1002/mc.22942
By:
- Liu, Wen‐Bin;
- Han, Fei;
- Huang, Yong‐Sheng;
- Chen, Hong‐Qiang;
- Chen, Jian‐Ping;
- Wang, Dan‐Dan;
- Jiang, Xiao;
- Yin, Li;
- Cao, Jia;
- Liu, Jin‐Yi
Publication type:
Article
DSCAM‐AS1 promotes tumor growth of breast cancer by reducing miR‐204‐5p and up‐regulating RRM2.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 461, doi. 10.1002/mc.22941
By:
- Liang, Wen‐Hui;
- Li, Na;
- Yuan, Zhi‐Qing;
- Qian, Xin‐Lai;
- Wang, Zhi‐Hui
Publication type:
Article
Issue Information ‐ Ed Board.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 459, doi. 10.1002/mc.22857
Publication type:
Article
HMGB1‐RAGE signaling facilitates Ras‐dependent Yap1 expression to drive colorectal cancer stemness and development.
Published in:
Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 500, doi. 10.1002/mc.22944
By:
- Qian, Fei;
- Xiao, Jianjia;
- Gai, Ling;
- Zhu, Jianwei
Publication type:
Article